Patients with type 2 diabetes
Conditions
Interventions
Sponsors
Sakaguchi Kazuhiko
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with type 2 diabetes 2.Patients taking more than 1000 mg of metformin hydrochloride per day 3.Patients with no obvious lesions in the lower gastrointestinal tract 4.Patients who were 20 years of age or older and Under 75 years old at the time of obtaining consent 5.Patients who have given their voluntary written consent to participate in this clinical study
Exclusion criteria
Exclusion criteria: 1.Patients with contraindications to scopolamine butylbromide 2.Patients suffering from dementia or mental illness 3.Patients with possible bowel perforation or obstruction 4.Patients with metals in the body that are not amenable to PET/MRE testing 5.Pregnant or breast feeding patients 6.Other patients who are deemed inappropriate by the investigators of this clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FDG excretion per hour into the intestinal lumen | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1c, plasma glucose levels and various clinical parameters Presence or absence of disease | — |
Contacts
Public ContactJun Ito
Kobe University Hospital
Outcome results
None listed